|
|
Volumn 5, Issue 15, 2013, Pages 1709-1718
|
|
Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIODARONE;
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANTIPROTOZOAL AGENT;
BENZNIDAZOLE;
E 1224;
EFLORNITHINE;
FEXINIDAZOLE;
MEGLUMINE;
MEGLUMINE ANTIMONATE;
MELARSOPROL;
MILTEFOSINE;
NIFURTIMOX;
OXABOROLE;
PAFURAMIDINE;
PAROMOMYCIN;
PENTAMIDINE;
POSACONAZOLE;
SCYX 7158;
STEROL 14ALPHA DEMETHYLASE INHIBITOR;
STIBOGLUCONATE SODIUM;
SURAMIN;
UNCLASSIFIED DRUG;
AFRICAN TRYPANOSOMIASIS;
ARTHRALGIA;
CHAGAS DISEASE;
CLINICAL TRIAL (TOPIC);
DIZZINESS;
DRUG EFFICACY;
DRUG FATALITY;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG SCREENING;
GOVERNMENT;
HEART ARRHYTHMIA;
HIGH THROUGHPUT SCREENING;
HUMAN;
HYPOTENSION;
LEISHMANIA;
LEISHMANIASIS;
MOTIVATION;
NAUSEA;
NAUSEA AND VOMITING;
NONHUMAN;
ORGANIZATION;
PHENOTYPE;
PRIORITY JOURNAL;
REVIEW;
SKIN LEISHMANIASIS;
STANDARDIZATION;
SYSTEMIC MYCOSIS;
TRYPANOSOMA BRUCEI;
TRYPANOSOMA CRUZI;
TRYPANOSOMIASIS;
VISCERAL LEISHMANIASIS;
ANTIPROTOZOAL AGENTS;
CHAGAS DISEASE;
DRUG EVALUATION, PRECLINICAL;
HIGH-THROUGHPUT SCREENING ASSAYS;
HUMANS;
LEISHMANIASIS;
PUBLIC-PRIVATE SECTOR PARTNERSHIPS;
TRYPANOSOMIASIS, AFRICAN;
|
|
EID: 84886555633
PISSN: 17568919
EISSN: 17568927
Source Type: Journal
DOI: 10.4155/fmc.13.161 Document Type: Review |
|
Times cited : (10)
|
|
References (4)
|
